Cargando…

Prognostic Markers in Patients with Ascites and Hepatorenal Syndrome

Detalles Bibliográficos
Autores principales:	Nazal, Leyla, Cárdenas, Andrés
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2011
Materias:	Other
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826924/ https://www.ncbi.nlm.nih.gov/pubmed/22045399 http://dx.doi.org/10.3233/DMA-2011-0836

Ejemplares similares

Role of Terlipressin in Cirrhotic Patients with Ascites and without Hepatorenal Syndrome: A Systematic Review of Current Evidence
por: Bai, Zhaohui, et al.
Publicado: (2020)

Hepatorenal Syndrome
por: Kiser, Tyree H.
Publicado: (2014)

Ascites, refractory ascites and hyponatremia in cirrhosis
por: Fortune, Brett, et al.
Publicado: (2017)

Markers of cell death predict therapy response in patients with cirrhosis and hepatorenal syndrome
por: Heinrich, Sophia, et al.
Publicado: (2022)

Metabolic syndrome and the hepatorenal reflex
por: Wider, Michael D.
Publicado: (2016)

Metabolic syndrome and the hepatorenal reflex
por: Wider, Michael D.
Publicado: (2016)

A Review of Hepatorenal Syndrome
por: Subedi, Abinash, et al.
Publicado: (2021)

COVID-19 and hepatorenal syndrome
por: Wu, Henry H L, et al.
Publicado: (2022)

Optimal management of hepatorenal syndrome in patients with cirrhosis
por: Angeli, Paolo, et al.
Publicado: (2010)

Invasive hemodynamic parameters in patients with hepatorenal syndrome
por: Pelayo, Jerald, et al.
Publicado: (2022)

Hepatorenal Syndrome: Aetiology, Diagnosis, and Treatment
por: Low, G., et al.
Publicado: (2015)

Commentary: Metabolic syndrome and the hepatorenal reflex
por: Wider, Michael D.
Publicado: (2016)

Erratum: Metabolic syndrome and the hepatorenal reflex
Publicado: (2017)

Hepatorenal syndrome: Update on diagnosis and therapy
por: Acevedo, Juan G, et al.
Publicado: (2017)

Hepatorenal syndrome in children: a review
por: Liu, Priscila Menezes Ferri, et al.
Publicado: (2020)

Management of Hepatorenal Syndrome: A Review
por: Tariq, Raseen, et al.
Publicado: (2020)

Liver Kidney Crosstalk: Hepatorenal Syndrome
por: Nassar, Mahmoud, et al.
Publicado: (2021)

Deranged Biochemical Markers As Early Predictors for the Development of Hepatorenal Syndrome in Patients With Alcoholic Liver Cirrhosis
por: Deorukhkar, Durga, et al.
Publicado: (2023)

Development and validation of a prognostic model for patients with hepatorenal syndrome: A retrospective cohort study
por: Sheng, Xin-Yu, et al.
Publicado: (2021)

Hepatorenal tyrosinemia
por: KITAGAWA, Teruo
Publicado: (2012)

Effects of plasma expansion with albumin and paracentesis on haemodynamics and kidney function in critically ill cirrhotic patients with tense ascites and hepatorenal syndrome: a prospective uncontrolled trial
por: Umgelter, Andreas, et al.
Publicado: (2008)

Combined Liver-Kidney Transplantation for Hepatorenal Syndrome
por: Kanubhai Sutariya, V., et al.
Publicado: (2015)

Acute kidney injury and hepatorenal syndrome in cirrhosis
por: Gupta, Kapil, et al.
Publicado: (2021)

Recent advances in the understanding and management of hepatorenal syndrome
por: Simbrunner, Benedikt, et al.
Publicado: (2021)

Hepatorenal syndrome: Current concepts and future perspectives
por: Jung, Chan-Young, et al.
Publicado: (2023)

Prognostic and Predictive Markers in Cancer
por: Conley, Barbara A., et al.
Publicado: (2004)

Renal blood flow in cirrhotic patients and hepatorenal syndrome (HRS)
por: Nagi, HK, et al.
Publicado: (2002)

Is MELD score failing patients with liver disease and hepatorenal syndrome?
por: Sibulesky, Lena, et al.
Publicado: (2016)

The Effect of Terlipressin on Renal Replacement Therapy in Patients with Hepatorenal Syndrome
por: Velez, Juan Carlos Q., et al.
Publicado: (2023)

Prognostic impact of hepatorenal function in patients undergoing transcatheter tricuspid valve repair
por: Tanaka, Tetsu, et al.
Publicado: (2021)

Prognostic Nomograms for Hospital Survival and Transplant-Free Survival of Patients with Hepatorenal Syndrome: A Retrospective Cohort Study
por: Song, Yi, et al.
Publicado: (2022)

Hepatorenal syndrome: one size does not fit all
por: Parikh, Amay, et al.
Publicado: (2012)

Hepatorenal Syndrome: Outcome of Response to Therapy and Predictors of Survival
por: Heidemann, Jan, et al.
Publicado: (2015)

Hepatorenal syndrome:Response to terlipressin and albumin and its determinants
por: Sarwar, Shahid, et al.
Publicado: (2016)

CONFIRMing Hepatorenal Syndrome Management: #NephJC Editorial
por: Willows, Jamie, et al.
Publicado: (2021)

Responsiveness to Vasoconstrictor Therapy in Hepatorenal Syndrome Type 1
por: Velez, Juan Carlos Q., et al.
Publicado: (2023)

Good Enough? Terlipressin, Hepatorenal Syndrome, and the Usage of RRT
por: Belcher, Justin M.
Publicado: (2023)

Following the MAP for Improved Kidney Function in Hepatorenal Syndrome
por: Thau, Matthew R., et al.
Publicado: (2023)

Prognostic Markers in Patients with Cirrhosis and Portal Hypertension Who Have Not Bled
por: Poca, Maria, et al.
Publicado: (2011)

Diagnostic and Prognostic Molecular Markers in Hepatocellular Carcinoma
por: Mínguez, Beatriz, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_crf61qd6falm5lgu5afl74l6f2